GLP-1 Manufacturer Rebate Programs 2026: Which Treatments Save You the Most
Novo Nordisk and Eli Lilly both offer manufacturer savings programs that can cut your GLP-1 costs by 75–98%. Here's every program, who qualifies, and how to maximize your savings.
Manufacturer rebate programs are the single most effective way to reduce the cost of brand-name GLP-1 medications. With list prices running $935–$1,349 per month, these programs can drop your out-of-pocket cost to as little as $25 per month — or even $0 in some cases.
But each program has different eligibility rules, caps, and expiration dates. This guide covers every manufacturer savings program available in 2026 so you can determine which ones apply to your situation.
Key Takeaways
- Manufacturer savings cards can reduce brand-name GLP-1 costs to $25/month with commercial insurance
- NovoCare Pharmacy offers $149–$349/month cash-pay without insurance for Wegovy and Rybelsus
- LillyDirect offers Zepbound vials at $499/month flat rate for uninsured patients
- Patient assistance programs provide free medication for qualifying low-income patients
- Medicare and Medicaid patients are not eligible for manufacturer savings cards but have other options
Novo Nordisk Programs (Wegovy, Ozempic, Rybelsus)
Wegovy Savings Card
Who qualifies: Patients with commercial insurance that covers Wegovy. Not available for Medicare, Medicaid, or government-funded programs.
How it works: After your insurance processes the claim, the savings card covers up to $100 of your remaining copay. Most patients pay $25 or less per fill.
Fine print: Maximum savings of $100 per 28-day supply. Card must be re-enrolled annually. Some plans that exclude weight-loss medications won't trigger the savings card because insurance never processes the initial claim.
NovoCare Pharmacy Direct (Cash-Pay)
Who qualifies: Any US patient, regardless of insurance status. This is Novo Nordisk's direct-to-patient cash-pay channel.
What you'll pay:
- Rybelsus (oral semaglutide): $149/month for 1.5 mg and 4 mg tablets (through August 2026)
- Wegovy 0.25 mg and 0.5 mg (starter): $199/month (through June 2026)
- Wegovy standard pens (0.25–2.4 mg range): $349/month
- Wegovy HD 7.2 mg pen: $399/month
Fine print: Intro pricing on starter doses is temporary — confirm current pricing before enrolling. These are self-pay prices and cannot be combined with insurance.
Ozempic Savings Card
Who qualifies: Patients with commercial insurance covering Ozempic for type 2 diabetes.
How it works: Same structure as the Wegovy card — up to $100 per fill in savings. Since Ozempic is approved for diabetes (not weight loss), insurance coverage rates are generally higher.
Fine print: Off-label Ozempic use for weight loss may not qualify if your insurance doesn't cover it. Medicare/Medicaid excluded.
NovoCare Patient Assistance Program (Free Medication)
Who qualifies: US residents without insurance (or with insurance that doesn't cover the medication) and household income at or below specific thresholds. Application requires income documentation.
Fine print: Approval takes 2–4 weeks. Must re-apply periodically. Available for Wegovy, Ozempic, and Rybelsus.
Eli Lilly Programs (Zepbound, Mounjaro)
Zepbound Savings Card
Who qualifies: Patients with commercial insurance covering Zepbound for weight management or obstructive sleep apnea.
How it works: Reduces copay to $25 or less per fill. Savings capped at a set dollar amount per prescription period.
Fine print: Not available for government insurance programs. Insurance must cover Zepbound for the card to apply.
LillyDirect Zepbound Vials (Cash-Pay)
Who qualifies: Any US patient, with or without insurance. This is the standout cash-pay program for tirzepatide in 2026.
What makes it unique: Unlike most pricing structures that increase with dose, LillyDirect charges the same $499/month whether you're on 2.5 mg or 15 mg. You receive single-dose vials and draw your dose with a syringe.
Fine print: Requires self-administration with syringe (not KwikPen). Prescription from a licensed provider still required.
Mounjaro Savings Card
Who qualifies: Patients with commercial insurance covering Mounjaro for type 2 diabetes.
Fine print: No equivalent cash-pay program exists for Mounjaro. Without insurance coverage, patients pay approximately $1,069/month at retail.
Lilly Cares Patient Assistance (Free Medication)
Who qualifies: US residents meeting income guidelines, without adequate insurance coverage for Mounjaro or Zepbound.
Fine print: Requires application with income verification. Processing time varies.
Quick Comparison: All Programs at a Glance
| Program | Your Cost | Insurance Required? | Medicare Eligible? |
|---|---|---|---|
| Wegovy Savings Card | $25/mo | Yes (commercial) | No |
| Ozempic Savings Card | $25/mo | Yes (commercial) | No |
| NovoCare Cash-Pay | $149–$399/mo | No | Yes (cash-pay) |
| Zepbound Savings Card | $25/mo | Yes (commercial) | No |
| LillyDirect Vials | $499/mo | No | Yes (cash-pay) |
| Mounjaro Savings Card | $25/mo | Yes (commercial) | No |
| Patient Assistance (Either) | $0/mo | No | Varies |
What About Medicare Patients?
Medicare patients cannot use manufacturer savings cards — federal rules prohibit it. However, two developments in 2026 are improving access:
Mounjaro on Medicare Part D: If you have type 2 diabetes, Medicare Part D covers Mounjaro. Your cost depends on your plan's formulary tier, but many patients pay around $50/month after reaching catastrophic coverage.
Zepbound GLP-1 Bridge Program: Starting July 1, 2026, eligible Medicare beneficiaries can access Zepbound through a new bridge program at approximately $50/month. This is a significant development for Medicare patients who need weight management medication.
Medicare patients can also access NovoCare and LillyDirect cash-pay programs, though at the self-pay prices listed above rather than the savings-card rates.
Step 1: Check if your insurance covers any GLP-1 medication. Step 2: If covered, apply for the manufacturer savings card (free, takes 5 minutes). Step 3: If not covered, compare NovoCare cash-pay ($149–$349/mo for semaglutide) vs. LillyDirect ($499/mo for tirzepatide) vs. compounded options. Step 4: If income-qualified, apply for patient assistance for free medication.
Compare All GLP-1 Provider Pricing
See which providers offer the best combination of medication cost, savings program compatibility, and clinical support.
Compare Providers →Paid link · We may earn a commission if you sign up through our links